Panic Disorders Market Report 2024 Latest Insights, Growth Rate, Future Trends And Forecast | Key Players : F. Hoffmann-La Roche Ltd, Sanofi S.A, Bristol-Myers Squibb Company, AstraZeneca plc, Abbott Laboratories

"The new report published by The Business Research Company, titled ""Panic Disorders Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033"", delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.

As per the report, the panic disorders market size has grown strongly in recent years. It will grow from $10.19 billion in 2023 to $10.73 billion in 2024 at a compound annual growth rate (CAGR) of 5.3%. The panic disorders market size is expected to see strong growth in the next few years. It will grow to $13.07 billion in 2028 at a compound annual growth rate (CAGR) of 5.1%.

Download Free Sample Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=13191&type=smp

Rising Number Of Psychiatric Patients Expected To Drive Panic Disorder Market Growth
An increase in the number of psychiatric patients is expected to propel the growth of the panic disorder market going forward. Psychiatric patients are individuals afflicted by psychiatric disorders or mental illnesses, which can disrupt cognition, emotions, and social behavior, resulting in panic disorder or panic attacks marked by sudden intensity. Treatment for psychiatric patients with panic disorder typically involves a combination of therapeutic approaches, medication, and lifestyle changes to alleviate the symptoms of panic attacks, improve the patient's overall quality of life, and help them manage and cope with condition effectively. For instance, in October 2022, according to the State of Mental Health in America 2022 report published by Mental Health America, a US-based non-profit organization associated with mental health promotion, the number of psychiatric patients or adults with any mental illnesses increased to 49,564,000, representing 19.86% of the total US population in 2022, compared with 47,132,000, representing 19.00% of the total US population in 2021. Therefore, the increase in the number of psychiatric patients will drive the growth of the panic disorder market.

Pharmaceutical Companies Focus On Extended-Release Capsules For Panic Disorder Treatment Advancements
Major companies operating in the panic disorder market are focusing on developing advanced medicines, such as extended-release capsules, to sustain their position in the market. Extended-release capsules are medications that release the active ingredient slowly over a while, typically 12 or 24 hours, to treat conditions requiring medication to be taken over a long period. For instance, in May 2023, Granules India Ltd., an India-based pharmaceutical company, received abbreviated new drug application (ANDA) approval from the US Food & Drug Administration (USFDA) for Venlafaxine hydrochloride extended-release capsules. It demonstrates bioequivalence with the reference-listed drug product (RLD), Effexor XR Extended-Release Capsules, manufactured by Upjohn US 2 LLC. Venlafaxine HCl extended-release capsules are prescribed for the management of conditions including generalized anxiety disorder (GAD), major depressive disorder (MDD), panic disorder (PD), and social anxiety disorder (SAD). They work by increasing the levels of serotonin and norepinephrine in the brain, and the dosage is usually started at 75 mg per day and may be increased by the doctor as needed.

The panic disorders market covered in this report is segmented -

1) By Type: Agoraphobia, Social Anxiety Disorder (SAD), Obsessive-Compulsive Disorder (OCD), Bipolar Disorder, Post-Traumatic Stress Disorder (PTSD), Major Depressive Disorder
2) By Treatment: Medication, Beta Blockers, Serotonin And Norepinephrine Reuptake Inhibitors (SNRIs), Benzodiazepines, Anti-Epilepsy, Other Treatments
3) By Route Of Administration: Oral, Parenteral, Other Routes Of Administrations
4) By End Use: Hospital Pharmacies, Retailer Pharmacies, Online Pharmacy Stores

Buy Now & Get Exclusive Discount on this Report, Checkout link @
https://www.thebusinessresearchcompany.com/Discount?id=13191&type=discount

Major companies operating in the panic disorders market report are F. Hoffmann-La Roche Ltd, Sanofi S.A, Bristol-Myers Squibb Company, AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline plc, Eli Lilly and Company, Boehringer Ingelheim International GmbH., Baxter Inc, Teva Pharmaceutical Industries Ltd, Mylan N.V., Pfizer Inc., Sun Pharmaceutical Industries Ltd, Bausch Health Companies Inc., H. Lundbeck A/S, Shionogi & Co Ltd., Recordati S.p.A, Neurocrine Biosciences Inc, Neuraxpharm, Actavis Plc., Noven Pharmaceuticals Inc., Sumitomo Pharma Co. Ltd, VistaGen Therapeutics, Valeant Pharmaceuticals International Inc., LIFECARE NEURO PRODUCTS LTD.

Contents of the report:
1. Executive Summary
2. Panic Disorders Market Report Structure
3. Panic Disorders Market Trends And Strategies
4. Panic Disorders Market - Macro Economic Scenario
5. Panic Disorders Market Size And Growth
…..
27. Panic Disorders Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Explore the report store to make a direct purchase of the report @ https://www.thebusinessresearchcompany.com/report/panic-disorders-global-market-report

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ "

Learn More About The Business Research Company

The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.